Literature DB >> 26697406

Corrigendum: Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.

Thomas Paul Slavin1, Mariana Niell-Swiller1, Ilana Solomon1, Bita Nehoray1, Christina Rybak1, Kathleen R Blazer1, Jeffrey N Weitzel1.   

Abstract

[This corrects the article on p. 208 in vol. 5, PMID: 26484312.].

Entities:  

Keywords:  BRCA1; genetic counseling; genetics; multigene panels

Year:  2015        PMID: 26697406      PMCID: PMC4667011          DOI: 10.3389/fonc.2015.00271

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


On page 4 of our manuscript, line 528, there is an erroneous reference for Figure 3. “Mosaic TP53 Case 2 is a 42-year-old unaffected woman of Northern European ancestry referred for interpretation of ambiguous results from a breast focused multigene panel ordered by her referring physician due to her maternal family history of cancer (Figure 3);” Figure 3 only pertains to the CDH1 case above (correctly referenced there). Therefore, the sentence should read: “Case 2 is a 42-year-old unaffected woman of Northern European ancestry referred for interpretation of ambiguous results from a breast focused multigene panel ordered by her referring physician due to her maternal family history of cancer;” We apologize for any confusion this may have caused.

Conflict of Interest Statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  3 in total

1.  Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study.

Authors:  Xin Niu; Laura M Amendola; Ragan Hart; Caroline S Bennette; Patrick Heagerty; Martha Horike-Pyne; Susan B Trinidad; Elisabeth A Rosenthal; Bryan Comstock; Chris Nefcy; Fuki M Hisama; Robin L Bennett; William M Grady; Carlos J Gallego; Peter Tarczy-Hornoch; Stephanie M Fullerton; Wylie Burke; Dean A Regier; Michael O Dorschner; Brian H Shirts; Peggy D Robertson; Deborah A Nickerson; Donald L Patrick; Gail P Jarvik; David L Veenstra
Journal:  Contemp Clin Trials       Date:  2019-08-07       Impact factor: 2.226

2.  Patient communication of cancer genetic test results in a diverse population.

Authors:  Charité N Ricker; Rachel B Koff; Chenxu Qu; Julie Culver; Duveen Sturgeon; Kerry E Kingham; Katrina Lowstuter; Nicolette M Chun; Courtney Rowe-Teeter; Alexandra Lebensohn; Peter Levonian; Katlyn Partynski; Karlena Lara-Otero; Christine Hong; Iva M Petrovchich; Meredith A Mills; Anne-Renee Hartman; Brian Allen; Uri Ladabaum; Kevin McDonnell; James M Ford; Stephen B Gruber; Allison W Kurian; Gregory E Idos
Journal:  Transl Behav Med       Date:  2018-01-29       Impact factor: 3.046

3.  The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.

Authors:  Thomas P Slavin; Kara N Maxwell; Jenna Lilyquist; Joseph Vijai; Kenneth Offit; Katherine L Nathanson; Fergus J Couch; Susan L Neuhausen; Steven N Hart; Vignesh Ravichandran; Tinu Thomas; Ann Maria; Danylo Villano; Kasmintan A Schrader; Raymond Moore; Chunling Hu; Bradley Wubbenhorst; Brandon M Wenz; Kurt D'Andrea; Mark E Robson; Paolo Peterlongo; Bernardo Bonanni; James M Ford; Judy E Garber; Susan M Domchek; Csilla Szabo; Jeffrey N Weitzel
Journal:  NPJ Breast Cancer       Date:  2017-06-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.